Agonist-triggered modulation of the activated and silent state of the vitamin D3 receptor by interaction with co-repressors and co-activators

Journal of Molecular Biology

Volumn 304, Issue 5, 2000, Pages 793-801

  Herdick, M ^a   Carlberg, C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Co repressors; Gene regulation; Nuclear receptors; Receptor conformations; Vitamin D receptor agonists

Indexed keywords

CALCITRIOL RECEPTOR; COLECALCIFEROL; PROTEIN TYROSINE KINASE; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STABILITY; TRANSACTIVATION;

EID: 0034671337     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4267     Document Type: Article

References (37)

1. 3
2. 3 receptor in the context of the nuclear receptor superfamily: The central role of retinoid X receptor
3. 3. Interplay with retinoid and thyroid hormone signalling
4. Crystal structure of the nuclear receptor for vitamin D bound to its natural ligand
5. The nuclear receptor ligand-binding domain: Structure and function
6. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
7. Alien, a highly conserved protein with characteristics of a co-repressor for members of the nuclear hormone receptor superfamily
8. Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors
9. Steroid receptor co-activator-1 is a histone acetyltransferase
10. Composite co-activator ARC mediates chromatin-directed transcriptional activation
11. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
12. Increasing the complexity of coactivation in nuclear receptor signaling
13. The vitamin D system
14. Newly identified actions of the vitamin D endocrine system
15. Structure-function relationships in the vitamin D endocrine system
16. Metabolism of the vitamin D analog EB1089: Identification of in vivo and in vitro liver metabolites and their biological activities
17. EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro
18. 3 analog with two side-chains
19. Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoid X receptor
20. 3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity
21. 3 are associated with enhanced activation of the vitamin D receptor
22. 3 receptor is functionally linked to the transactivation domain 2 (AF-2)
23. 3 analogues and their 20-epi homologues with the vitamin D receptor
24. 3 receptor
25. 3 receptor
26. 3 is mediated by a lack of ligand-induced vitamin D receptor interaction with co-activators
27. 3 signaling
28. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity
29. 3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity
30. Mechanism of co-repressor binding and release from nuclear hormone receptors
31. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or co-repressor binding
32. Co-activators and co-repressors in the integration of transcriptional responses
33. Two nuclear signalling pathways for vitamin D
34. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα
35. 3 receptor binding site found in the rat atrial natriuretic factor promoter
36. Sequence and characterization of a co-activator for the steroid hormone receptor superfamily
37. 3 receptor and the retinoid X receptor on DNA